Postoperative Safety Profile of Minimally Invasive Ileocolonic Resections for Crohn’s Disease in the Era of Biologic Therapy

Hypoalbuminemia, Not Biologic Exposure, is Associated with Postoperative Complications in Crohn’s Disease Patients Undergoing Ileocolic Resection

(2021) Ravi S Shah et al.   Journal of Crohns & Colitis

Trends and consequences of surgical conversion in the United States

(2021) Mohamed A. Abd El Aziz et al.   SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES

Systematic Review and Meta-Analysis: Preoperative Vedolizumab and Postoperative Complications in Patients with IBD

(2021) Zain Moosvi et al.   SOUTHERN MEDICAL JOURNAL

The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Crohn’s Disease

(2020) Amy L. Lightner et al.   DISEASES OF THE COLON & RECTUM

Colectomy for patients with super obesity: current practice and surgical morbidity in the United States

(2020) Mohamed A. Abd El Aziz et al.   Surgery for Obesity and Related Diseases

Trends of complications and innovative techniques’ utilization for colectomies in the United States

(2020) Mohamed A. Abd El Aziz et al.   Updates in Surgery

Systematic review with meta-analysis: risk of post-operative complications associated with pre-operative exposure to anti-tumour necrosis factor agents for Crohn’s disease

(2019) Yang-Sheng Lin et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

415a – Anti-Tumor Necrosis Factor Therapy is Not Associated with Post-Operative Infection: Results from Prospective Cohort of Ulcerative Colitis and Crohn's Disease Patients Undergoing Surgery to Identify Risk Factors for Postoperative Infection I (Puccini)

(2019) Benjamin L. Cohen et al.   GASTROENTEROLOGY

ACG Clinical Guideline: Management of Crohn’s Disease in Adults

(2018) Gary R Lichtenstein et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Systematic Review and Meta-Analysis: Preoperative Vedolizumab Treatment and Postoperative Complications in Patients with Inflammatory Bowel Disease

(2018) Cindy C Y Law et al.   Journal of Crohns & Colitis

Surgical outcomes of patients treated with ustekinumab vs. vedolizumab in inflammatory bowel disease: a matched case analysis

(2018) Matteo Novello et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Postoperative Outcomes in Ustekinumab-Treated Patients Undergoing Abdominal Operations for Crohn’s Disease

(2017) Amy L Lightner et al.   Journal of Crohns & Colitis

Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis

(2016) E. J. Mao et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Abdominal Operations for Inflammatory Bowel Disease

(2016) Amy L. Lightner et al.   Journal of Crohns & Colitis

Risk of infections associated with biological treatment in inflammatory bowel disease

(2016) Nynne Nyboe Andersen et al.   WORLD JOURNAL OF GASTROENTEROLOGY

The Impact of Enhanced Recovery Protocol Compliance on Elective Colorectal Cancer Resection

(2015)   ANNALS OF SURGERY

Determining Predictors for Intra-abdominal Septic Complications Following Ileocolonic Resection for Crohn's Disease--Considerations in Pre-operative and Peri-operative Optimisation Techniques to Improve Outcome

(2015) P. S. Morar et al.   Journal of Crohns & Colitis

Outcomes after implementation of a multimodal standard care pathway for laparoscopic colorectal surgery

(2014) D. W. Larson et al.   BRITISH JOURNAL OF SURGERY

Improving Conventional Recovery With Enhanced Recovery in Minimally Invasive Surgery for Rectal Cancer

(2014) Wael Khreiss et al.   DISEASES OF THE COLON & RECTUM

Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979–2011

(2013) Christine Rungoe et al.   GUT

Intrathecal Analgesia and Restrictive Perioperative Fluid Management within Enhanced Recovery Pathway: Hemodynamic Implications

(2013) Martin Hübner et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

(2013) William J. Sandborn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Biologic Therapy and Surgery for Crohn Disease

(2013) E. Paulson   Clinics in Colon and Rectal Surgery

Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry

(2012) Gary R Lichtenstein et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Anti-tumor necrosis factor and postoperative complications in Crohnʼs disease: systematic review and meta-analysis

(2012) Uri Kopylov et al.   INFLAMMATORY BOWEL DISEASES

“How I Do It”—Radical Right Colectomy with Side-to-Side Stapled Ileo-Colonic Anastomosis

(2012) M. Hübner et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Case-matched series of enhanced versus standard recovery pathway in minimally invasive colorectal surgery

(2011) J. K. Lovely et al.   BRITISH JOURNAL OF SURGERY

Certolizumab Pegol for Active Crohn's Disease: A Placebo-Controlled, Randomized Trial

(2011) William J. Sandborn et al.   Clinical Gastroenterology and Hepatology

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

(2010) Jean Frédéric Colombel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Laparoscopic surgery for recurrent ileocolic Crohnʼs disease†

(2009) Stefan D. Holubar et al.   INFLAMMATORY BOWEL DISEASES